Theseus Pharmaceuticals Stock Filter Stocks by Fundamentals
THRXDelisted Stock | USD 4.06 0.00 0.00% |
Theseus Pharmaceuticals fundamentals help investors to digest information that contributes to Theseus Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Theseus Stock. The fundamental analysis module provides a way to measure Theseus Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theseus Pharmaceuticals stock.
Theseus |
Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
All Next | Launch Module |
Theseus Fundamentals
Return On Equity | -0.26 | |||
Return On Asset | -0.18 | |||
Current Valuation | (20.19 M) | |||
Shares Outstanding | 44.65 M | |||
Shares Owned By Insiders | 2.55 % | |||
Shares Owned By Institutions | 93.28 % | |||
Number Of Shares Shorted | 401.68 K | |||
Price To Earning | 737.67 X | |||
Price To Book | 0.81 X | |||
EBITDA | (66.44 M) | |||
Net Income | (56.61 M) | |||
Cash And Equivalents | 212.43 M | |||
Cash Per Share | 5.55 X | |||
Total Debt | 3.98 M | |||
Debt To Equity | 0.02 % | |||
Current Ratio | 27.54 X | |||
Book Value Per Share | 5.17 X | |||
Cash Flow From Operations | (49.63 M) | |||
Short Ratio | 0.82 X | |||
Earnings Per Share | (1.34) X | |||
Target Price | 5.25 | |||
Number Of Employees | 38 | |||
Beta | 3.98 | |||
Market Capitalization | 181.28 M | |||
Total Asset | 222.45 M | |||
Retained Earnings | (112.19 M) | |||
Working Capital | 190.99 M | |||
Current Asset | 223.75 M | |||
Current Liabilities | 11.28 M | |||
Z Score | 26.67 | |||
Net Asset | 222.45 M |
About Theseus Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theseus Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. Theseus Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Theseus Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Theseus Pharmaceuticals' short interest history, or implied volatility extrapolated from Theseus Pharmaceuticals options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |